Adjuvatis participates to the Vaccinnov’Day, November 25th, 2014 in Paris, France, organized by:
CVT Aviesan & DVS Innovation in Vaccinology
VaccInnov Day aims at valuing the potential and scientific wealth of innovative projects in Vaccinology.
More information about the event, here: Vaccinnov Day
More information about the organizers:
“CVT Aviesan - Consortium de Valorisation Thématique Aviesan is a national structure created since 2012 and accredited under the governmental plan for Future Investments.
The strategic tech transfer consortium from Aviesan aims to coordinate the policies, strengths and expertise of its stakeholders* in the fields of life sciences and health. This is possible through several Strategic Axis (‘Domaines de Valorisation Stratégique’, or ‘DVS’, in French) whose goal is to provide national analyses and actions for their scientific and industrial communities, to promote partnering opportunities.”
“Domaine de Valorisation Stratégique Innovation en Vaccinologie is coordinated by Inserm Transfert and Institut Pasteur. CoReVac & DVS Innovation in Vaccinology join together to make translation of breakthrough research into innovative vaccines easier. On the basis of strategic analysis (Intellectual Property, International Benchmarks) and French academic strengths mapping in Vaccinology, DVS aims to point out innovative collaborative projects as well as to inform and involve funders such as technology acceleration and transfer companies (SATTs), the French National Research Agency (ANR) or the Public Investment Bank (BPi), and thereby promote potential for industrial transfer.”